# Hashdex Nasdaq CME Crypto Index ETF: financial statements, quarterly

NCIQ · Nasdaq · CIK 2031069 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nciq.md) · [Financials](/companies/nciq/financials.md) · [Filings](/companies/nciq/filings.md) · [Insiders](/companies/nciq/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nciq/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating income | $m | not reported | [0.0](/filings/0001213900-25-107940.md) | not reported | not reported |
| Net income | $m | [27.9](/filings/0001213900-26-088407.md) | [16.5](/filings/0001213900-25-107940.md) | [(29.5)](/filings/0001213900-26-055154.md) | [(23.9)](/filings/0001213900-26-088407.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001213900-25-045123.md) | [0.1](/filings/0001213900-25-074441.md) | [0.2](/filings/0001213900-25-107940.md) | [0.1](/filings/0001213900-26-088407.md) | [0.1](/filings/0001213900-26-055154.md) | [0.2](/filings/0001213900-26-088407.md) |
| Total assets | $m | [88.7](/filings/0001213900-25-045123.md) | [126](/filings/0001213900-25-074441.md) | [157](/filings/0001213900-25-107940.md) | [121](/filings/0001213900-26-088407.md) | [98.1](/filings/0001213900-26-055154.md) | [190](/filings/0001213900-26-088407.md) |
| Total liabilities | $m | [0.0](/filings/0001213900-25-045123.md) | [0.0](/filings/0001213900-25-074441.md) | [3.7](/filings/0001213900-25-107940.md) | [0.0](/filings/0001213900-26-088407.md) | [0.0](/filings/0001213900-26-055154.md) | [0.0](/filings/0001213900-26-088407.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

Shares outstanding: 13,040,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-12](/filings/0001213900-26-088407.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.